SEC Form 4/A · accession 0001461959-17-000006
Q BioMed Inc. · QBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
William S Rosenstadt
Officer — General Counsel · Director · 10% Owner
Period of report
Jun 5, 2017
Accepted (ET)
Oct 4, 2017 · 5:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001596062
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock OptionF1 | $4.00 | Jun 5, 2017 | A | 12,500 | A | Sep 5, 2017 | Jun 5, 2022 | Common Stock | 12,500 | 462,500 | D |
| Incentive Stock OptionF2 | $4.00 | Jun 5, 2017 | A | 25,000 | A | Sep 5, 2017 | Jun 5, 2022 | Common Stock | 25,000 | 487,500 | D |
| WarrantF3 | $4.00 | Jun 5, 2017 | A | 350,000 | A | Dec 5, 2017 | Jun 5, 2022 | Common Stock | 350,000 | 837,500 | D |
Explanation of responses
- F1Issued for director services.
- F2Issued for officer services.
- F3Issued for business development services.
Remarks
This amendment reflects the proper amount of derivative securities beneficially owned in column 9 of table II.